Journal
INTERNATIONAL JOURNAL OF CANCER
Volume 131, Issue 3, Pages E244-E250Publisher
WILEY-BLACKWELL
DOI: 10.1002/ijc.26454
Keywords
autoimmunity; breast cancer; cancer; celiac; cohort study; celiac; gluten intolerance; inflammation; malignancy; population-based
Categories
Funding
- Orebro University Hospital Research Foundation
- Orebro University
- Swedish Society of Medicine
- Swedish Research Council
- Sven Jerring Foundation
- Orebro Society of Medicine
- Karolinska Institutet
- Clas Groschinsky Foundation
- Juhlin Foundation
- Majblomman Foundation
- Uppsala-Orebro Regional Research Council
- Swedish Celiac Society
- UK National Institute for Health Research
- Stockholm County Council
Ask authors/readers for more resources
Women with celiac disease (CD) may be at decreased risk of female hormone-related cancers given the observed reduction in breast cancer seen in some cohorts. Using biopsy data from all 28 pathology departments in Sweden, we identified 17,852 women with CD who were diagnosed between 1969 and 2007. We used Cox regression model to estimate their risk of breast, endometrial and ovarian cancer and then compared them with 88,400 age- and sex-matched controls. The results indicate that individuals with CD were at a lower risk for all three outcomes: breast cancer (hazard ratio, HR = 0.85; 95% CI = 0.721.01), endometrial cancer (HR = 0.60; 95% CI =0.410.86) and ovarian cancer (HR = 0.89; 95% CI =0.591.34). This inverse relationship was strengthened when we excluded the first year of follow-up beyond CD diagnosis (breast: HR = 0.82; 95% CI =0.680.99; endometrial: HR = 0.58; 0.390.87; ovarian cancer: HR = 0.72; 0.451.15). In conclusion, CD seems to be inversely related not only to breast cancer but also to endometrial and ovarian cancer. Potential explanations include shared risk factors and early menopause.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available